Improvement in the clinical manifestations of interstitial lung disease following treatment with placental mesenchymal stromal cell extracellular vesicles in a patient with systemic sclerosis: A case report
Interstitial lung disease (ILD) is a severe systemic sclerosis (SSc) complication with no current approved or golden standard treatment. This report aims to investigate the effectiveness of treatment with placental mesenchymal stromal cell (MSC) extracellular vesicles (EVs) in a patient with ILD due...
Saved in:
Published in | Respiratory medicine case reports Vol. 46; p. 101923 |
---|---|
Main Authors | , , , , , , , , |
Format | Journal Article |
Language | English |
Published |
Elsevier Ltd
01.01.2023
Elsevier |
Subjects | |
Online Access | Get full text |
Cover
Loading…
Abstract | Interstitial lung disease (ILD) is a severe systemic sclerosis (SSc) complication with no current approved or golden standard treatment. This report aims to investigate the effectiveness of treatment with placental mesenchymal stromal cell (MSC) extracellular vesicles (EVs) in a patient with ILD due to SSc.
The patient was a 55-year-old woman with a ten years history of SSc complicated by severe ILD. Over time, her lung disease progressed to interstitial fibrosis despite being treated with mycophenolate mofetil and monthly pulses of cyclophosphamide. Thus, she was treated with eight doses of placenta MSC-EVs. Four weeks after the third dose (Day 31 after the first dose), she reported marked improvement in her clinical symptoms, such as dyspnea and cough. Also, chest computed tomography (CT) scans demonstrated a significant reduction in ground glass consolidations and fibrotic changes. The patient was subsequently followed for twelve months, with findings showing significant improvement in exercise tolerance and reduced supplemental oxygen need.
In this single case, placental MSC-EVs were seen to provide a potentially efficient treatment for SSc-related ILD; however, further investigation and clinical trials are necessary. |
---|---|
AbstractList | Interstitial lung disease (ILD) is a severe systemic sclerosis (SSc) complication with no current approved or golden standard treatment. This report aims to investigate the effectiveness of treatment with placental mesenchymal stromal cell (MSC) extracellular vesicles (EVs) in a patient with ILD due to SSc.
The patient was a 55-year-old woman with a ten years history of SSc complicated by severe ILD. Over time, her lung disease progressed to interstitial fibrosis despite being treated with mycophenolate mofetil and monthly pulses of cyclophosphamide. Thus, she was treated with eight doses of placenta MSC-EVs. Four weeks after the third dose (Day 31 after the first dose), she reported marked improvement in her clinical symptoms, such as dyspnea and cough. Also, chest computed tomography (CT) scans demonstrated a significant reduction in ground glass consolidations and fibrotic changes. The patient was subsequently followed for twelve months, with findings showing significant improvement in exercise tolerance and reduced supplemental oxygen need.
In this single case, placental MSC-EVs were seen to provide a potentially efficient treatment for SSc-related ILD; however, further investigation and clinical trials are necessary. Background: Interstitial lung disease (ILD) is a severe systemic sclerosis (SSc) complication with no current approved or golden standard treatment. This report aims to investigate the effectiveness of treatment with placental mesenchymal stromal cell (MSC) extracellular vesicles (EVs) in a patient with ILD due to SSc. Case presentation: The patient was a 55-year-old woman with a ten years history of SSc complicated by severe ILD. Over time, her lung disease progressed to interstitial fibrosis despite being treated with mycophenolate mofetil and monthly pulses of cyclophosphamide. Thus, she was treated with eight doses of placenta MSC-EVs. Four weeks after the third dose (Day 31 after the first dose), she reported marked improvement in her clinical symptoms, such as dyspnea and cough. Also, chest computed tomography (CT) scans demonstrated a significant reduction in ground glass consolidations and fibrotic changes. The patient was subsequently followed for twelve months, with findings showing significant improvement in exercise tolerance and reduced supplemental oxygen need. Conclusion: In this single case, placental MSC-EVs were seen to provide a potentially efficient treatment for SSc-related ILD; however, further investigation and clinical trials are necessary. |
ArticleNumber | 101923 |
Author | Norooznezhad, Amir Hossein Soufivand, Parviz Payandeh, Mehrdad Pournazari, Mehran Hassaninia, Daryoush Assar, Shirin Mohammadzadeh, Dena Yarani, Reza Mansouri, Kamran |
Author_xml | – sequence: 1 givenname: Shirin surname: Assar fullname: Assar, Shirin organization: Medical Biology Research Center, Health Technology Institute, Kermanshah University of Medical Sciences, Kermanshah, Iran – sequence: 2 givenname: Dena surname: Mohammadzadeh fullname: Mohammadzadeh, Dena organization: Clinical Research Development Center, Imam Reza Hospital, Kermanshah University of Medical Sciences, Kermanshah, Iran – sequence: 3 givenname: Amir Hossein surname: Norooznezhad fullname: Norooznezhad, Amir Hossein organization: Medical Biology Research Center, Health Technology Institute, Kermanshah University of Medical Sciences, Kermanshah, Iran – sequence: 4 givenname: Mehrdad surname: Payandeh fullname: Payandeh, Mehrdad organization: Clinical Research Development Center, Imam Reza Hospital, Kermanshah University of Medical Sciences, Kermanshah, Iran – sequence: 5 givenname: Daryoush surname: Hassaninia fullname: Hassaninia, Daryoush organization: Clinical Research Development Center, Imam Reza Hospital, Kermanshah University of Medical Sciences, Kermanshah, Iran – sequence: 6 givenname: Mehran surname: Pournazari fullname: Pournazari, Mehran organization: Clinical Research Development Center, Imam Reza Hospital, Kermanshah University of Medical Sciences, Kermanshah, Iran – sequence: 7 givenname: Parviz surname: Soufivand fullname: Soufivand, Parviz organization: Clinical Research Development Center, Imam Reza Hospital, Kermanshah University of Medical Sciences, Kermanshah, Iran – sequence: 8 givenname: Reza surname: Yarani fullname: Yarani, Reza organization: Medical Biology Research Center, Health Technology Institute, Kermanshah University of Medical Sciences, Kermanshah, Iran – sequence: 9 givenname: Kamran surname: Mansouri fullname: Mansouri, Kamran email: kmansouri@kums.ac.ir, kamranmansouri@gmail.com organization: Medical Biology Research Center, Health Technology Institute, Kermanshah University of Medical Sciences, Kermanshah, Iran |
BookMark | eNp9kttq3DAQQE1JoWmaH-iTfmC3utiyXQolhF4WAn1pn8VYHu9qkSUjaTfdn8w3VcqGkLxULzOay5kL8766cN5hVX1kdM0ok5_26zDrsOaUi2LouXhTXXLOxIrSll280N9V1zHuaX5t19OGX1YPm3kJ_ogzukSMI2mHRFvjjAZLZnBmwpggGe8i8VOOSBhiMslktz24LRlNRIhIJm-tvzfZkgJCeuTdm7QjiwWdPwWHEZ3eneasxxR8kRqtJfg3BSjawUIgR4xGW4ylHSBLLv7MiqeYcDaaxBwQfDTxM7khutQPuPiQPlRvJ7ARr5_kVfXn-7fftz9Xd79-bG5v7la6ljKtGOBABWUtBZScD4I1om8HNlE5yVHItq6xG9saJcpxaJpWDDWn4wAdayZALq6qzZk7etirJZgZwkl5MOrR4MNWQUhlDCVYi81Yi6ajGav7HvgwdL0UuqNMS5ZZX8-s5TDMOJZlBbCvoK89zuzU1h8Vo7n3TvaZwM8EnXcSA07PyYyqciJqr8qJqHIi6nwiOenLOQnzno4Gg4o6b1rjaALqlAcx_0v_B-WizeE |
CitedBy_id | crossref_primary_10_1002_jev2_12433 crossref_primary_10_1136_ard_2023_224092 |
Cites_doi | 10.3389/fcell.2021.600711 10.1007/s13770-021-00405-5 10.1111/jcmm.17114 10.1136/ard.60.6.577 10.1056/NEJMra0806188 10.3390/ijms20184337 10.1016/j.jaut.2021.102660 10.1016/j.jaut.2016.03.013 10.1016/j.rdc.2015.04.003 10.1016/j.autrev.2021.102978 10.1155/2019/4506303 |
ContentType | Journal Article |
Copyright | 2023 The Authors 2023 The Authors 2023 |
Copyright_xml | – notice: 2023 The Authors – notice: 2023 The Authors 2023 |
DBID | 6I. AAFTH AAYXX CITATION 5PM DOA |
DOI | 10.1016/j.rmcr.2023.101923 |
DatabaseName | ScienceDirect Open Access Titles Elsevier:ScienceDirect:Open Access CrossRef PubMed Central (Full Participant titles) DOAJ Directory of Open Access Journals |
DatabaseTitle | CrossRef |
DatabaseTitleList | |
Database_xml | – sequence: 1 dbid: DOA name: Directory of Open Access Journals url: https://www.doaj.org/ sourceTypes: Open Website |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Medicine |
EISSN | 2213-0071 |
ExternalDocumentID | oai_doaj_org_article_317e5d43580744c99a2bb8963c801c61 10_1016_j_rmcr_2023_101923 S2213007123001181 |
GroupedDBID | .1- .FO 0R~ 0SF 1B1 1P~ 1~5 457 4G. 53G 5VS 6I. 7-5 AACTN AAEDT AAEDW AAFTH AAIKJ AALRI AAXUO ABMAC ACGFS ADBBV ADEZE ADRAZ AEVXI AEXQZ AFCTW AFRHN AFTJW AGHFR AITUG AJUYK ALMA_UNASSIGNED_HOLDINGS AMRAJ AOIJS BAWUL BCNDV DIK EBS EJD EO9 EP2 EP3 FDB GROUPED_DOAJ HYE HZ~ IPNFZ IXB KQ8 M41 M48 M~E NCXOZ O-L O9- RIG ROL RPM SES SSZ XH2 Z5R AAYXX ADVLN AFJKZ AKRWK CITATION 5PM |
ID | FETCH-LOGICAL-c466t-1aeb030170ae622b315397b1f06f6d36744e8d74e6e6db5573b420dba815fae23 |
IEDL.DBID | RPM |
ISSN | 2213-0071 |
IngestDate | Tue Oct 22 15:13:29 EDT 2024 Tue Sep 17 21:29:33 EDT 2024 Thu Sep 26 17:11:29 EDT 2024 Sat Oct 14 15:51:05 EDT 2023 |
IsDoiOpenAccess | true |
IsOpenAccess | true |
IsPeerReviewed | true |
IsScholarly | true |
Keywords | Mesenchymal stromal cells Extracellular vesicles Interstitial lung disease Systemic sclerosis |
Language | English |
License | This is an open access article under the CC BY-NC-ND license. This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/). |
LinkModel | DirectLink |
MergedId | FETCHMERGED-LOGICAL-c466t-1aeb030170ae622b315397b1f06f6d36744e8d74e6e6db5573b420dba815fae23 |
OpenAccessLink | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10622869/ |
ParticipantIDs | doaj_primary_oai_doaj_org_article_317e5d43580744c99a2bb8963c801c61 pubmedcentral_primary_oai_pubmedcentral_nih_gov_10622869 crossref_primary_10_1016_j_rmcr_2023_101923 elsevier_sciencedirect_doi_10_1016_j_rmcr_2023_101923 |
PublicationCentury | 2000 |
PublicationDate | 2023-01-01 |
PublicationDateYYYYMMDD | 2023-01-01 |
PublicationDate_xml | – month: 01 year: 2023 text: 2023-01-01 day: 01 |
PublicationDecade | 2020 |
PublicationTitle | Respiratory medicine case reports |
PublicationYear | 2023 |
Publisher | Elsevier Ltd Elsevier |
Publisher_xml | – name: Elsevier Ltd – name: Elsevier |
References | Vonk, Smith, Sfikakis, Cutolo, Del Galdo, Seibold (bib2) 2021; 20 Rozier, Maumus, Maria, Toupet, Lai-Kee-Him, Jorgensen (bib5) 2021; 121 Colletti, Galardi, De Santis, Guidelli, Di Giannatale, Di Luigi (bib3) 2019; 20 Yu, Shen, Xie, Zhao, Jiang (bib7) 2021; 19 Binks, Passweg, Furst, McSweeney, Sullivan, Besenthal (bib12) 2001; 60 Norooznezhad, Yarani, Payandeh, Hoseinkhani, Kiani, Taghizadeh (bib9) 2022; 26 Abreu, Lopes-Pacheco, Weiss, Rocco (bib11) 2021; 9 Gabrielli, Avvedimento, Krieg (bib1) 2009; 360 Pope, Johnson (bib8) 2015; 41 Maria, Toupet, Maumus, Fonteneau, Le Quellec, Jorgensen (bib4) 2016; 70 de la Torre, Pérez-Lorenzo, Flores (bib10) 2019 Sun, Zhu, Feng, Lin, Yin, Jin (bib6) 2019; 2019 Maria (10.1016/j.rmcr.2023.101923_bib4) 2016; 70 Gabrielli (10.1016/j.rmcr.2023.101923_bib1) 2009; 360 Abreu (10.1016/j.rmcr.2023.101923_bib11) 2021; 9 de la Torre (10.1016/j.rmcr.2023.101923_bib10) 2019 Binks (10.1016/j.rmcr.2023.101923_bib12) 2001; 60 Norooznezhad (10.1016/j.rmcr.2023.101923_bib9) 2022; 26 Vonk (10.1016/j.rmcr.2023.101923_bib2) 2021; 20 Rozier (10.1016/j.rmcr.2023.101923_bib5) 2021; 121 Colletti (10.1016/j.rmcr.2023.101923_bib3) 2019; 20 Yu (10.1016/j.rmcr.2023.101923_bib7) 2021; 19 Pope (10.1016/j.rmcr.2023.101923_bib8) 2015; 41 Sun (10.1016/j.rmcr.2023.101923_bib6) 2019; 2019 |
References_xml | – volume: 60 start-page: 577 year: 2001 end-page: 584 ident: bib12 article-title: Phase I/II trial of autologous stem cell transplantation in systemic sclerosis: procedure related mortality and impact on skin disease publication-title: Ann. Rheum. Dis. contributor: fullname: Besenthal – volume: 26 start-page: 588 year: 2022 end-page: 592 ident: bib9 article-title: Human placental mesenchymal stromal cell-derived exosome-enriched extracellular vesicles for chronic cutaneous graft-versus-host disease: a case report publication-title: J. Cell Mol. Med. contributor: fullname: Taghizadeh – volume: 360 start-page: 1989 year: 2009 end-page: 2003 ident: bib1 publication-title: Scleroderma. N. Engl. J. Med. contributor: fullname: Krieg – volume: 70 start-page: 31 year: 2016 end-page: 39 ident: bib4 article-title: Human adipose mesenchymal stem cells as potent anti-fibrosis therapy for systemic sclerosis publication-title: J. Autoimmun. contributor: fullname: Jorgensen – volume: 20 year: 2021 ident: bib2 article-title: Pharmacological treatments for SSc-ILD: systematic review and critical appraisal of the evidence publication-title: Autoimmun. Rev. contributor: fullname: Seibold – volume: 20 start-page: 4337 year: 2019 ident: bib3 article-title: Exosomes in systemic sclerosis: messengers between immune, vascular and fibrotic components? publication-title: Int. J. Mol. Sci. contributor: fullname: Di Luigi – volume: 2019 year: 2019 ident: bib6 article-title: Exosomal miRNA Let-7 from menstrual blood-derived endometrial stem cells alleviates pulmonary fibrosis through regulating mitochondrial DNA damage publication-title: Oxid. Med. Cell. Longev. contributor: fullname: Jin – volume: 19 start-page: 141 year: 2021 end-page: 150 ident: bib7 article-title: The therapeutic effects of exosomes derived from human umbilical cord mesenchymal stem cells on scleroderma publication-title: Tissue. Eng. Regen. Med. contributor: fullname: Jiang – volume: 41 start-page: 383 year: 2015 end-page: 398 ident: bib8 article-title: New classification criteria for systemic sclerosis (scleroderma) publication-title: Rheum. Dis. Clin. N. Am. contributor: fullname: Johnson – start-page: 300 year: 2019 end-page: 302 ident: bib10 article-title: Human placenta-derived mesenchymal stromal cells: a review from basic research to clinical applications publication-title: Stromal Cells Structure, Function, and Therapeutic Implications contributor: fullname: Flores – volume: 121 year: 2021 ident: bib5 article-title: Mesenchymal stromal cells-derived extracellular vesicles alleviate systemic sclerosis via miR-29a-3p publication-title: J. Autoimmun. contributor: fullname: Jorgensen – volume: 9 year: 2021 ident: bib11 article-title: Mesenchymal stromal cell-derived extracellular vesicles in lung diseases: current status and perspectives publication-title: Front. Cell Dev. Biol. contributor: fullname: Rocco – volume: 9 year: 2021 ident: 10.1016/j.rmcr.2023.101923_bib11 article-title: Mesenchymal stromal cell-derived extracellular vesicles in lung diseases: current status and perspectives publication-title: Front. Cell Dev. Biol. doi: 10.3389/fcell.2021.600711 contributor: fullname: Abreu – volume: 19 start-page: 141 issue: 1 year: 2021 ident: 10.1016/j.rmcr.2023.101923_bib7 article-title: The therapeutic effects of exosomes derived from human umbilical cord mesenchymal stem cells on scleroderma publication-title: Tissue. Eng. Regen. Med. doi: 10.1007/s13770-021-00405-5 contributor: fullname: Yu – volume: 26 start-page: 588 issue: 2 year: 2022 ident: 10.1016/j.rmcr.2023.101923_bib9 article-title: Human placental mesenchymal stromal cell-derived exosome-enriched extracellular vesicles for chronic cutaneous graft-versus-host disease: a case report publication-title: J. Cell Mol. Med. doi: 10.1111/jcmm.17114 contributor: fullname: Norooznezhad – volume: 60 start-page: 577 issue: 6 year: 2001 ident: 10.1016/j.rmcr.2023.101923_bib12 article-title: Phase I/II trial of autologous stem cell transplantation in systemic sclerosis: procedure related mortality and impact on skin disease publication-title: Ann. Rheum. Dis. doi: 10.1136/ard.60.6.577 contributor: fullname: Binks – volume: 360 start-page: 1989 issue: 19 year: 2009 ident: 10.1016/j.rmcr.2023.101923_bib1 publication-title: Scleroderma. N. Engl. J. Med. doi: 10.1056/NEJMra0806188 contributor: fullname: Gabrielli – volume: 20 start-page: 4337 issue: 18 year: 2019 ident: 10.1016/j.rmcr.2023.101923_bib3 article-title: Exosomes in systemic sclerosis: messengers between immune, vascular and fibrotic components? publication-title: Int. J. Mol. Sci. doi: 10.3390/ijms20184337 contributor: fullname: Colletti – volume: 121 year: 2021 ident: 10.1016/j.rmcr.2023.101923_bib5 article-title: Mesenchymal stromal cells-derived extracellular vesicles alleviate systemic sclerosis via miR-29a-3p publication-title: J. Autoimmun. doi: 10.1016/j.jaut.2021.102660 contributor: fullname: Rozier – volume: 70 start-page: 31 year: 2016 ident: 10.1016/j.rmcr.2023.101923_bib4 article-title: Human adipose mesenchymal stem cells as potent anti-fibrosis therapy for systemic sclerosis publication-title: J. Autoimmun. doi: 10.1016/j.jaut.2016.03.013 contributor: fullname: Maria – volume: 41 start-page: 383 issue: 3 year: 2015 ident: 10.1016/j.rmcr.2023.101923_bib8 article-title: New classification criteria for systemic sclerosis (scleroderma) publication-title: Rheum. Dis. Clin. N. Am. doi: 10.1016/j.rdc.2015.04.003 contributor: fullname: Pope – start-page: 300 year: 2019 ident: 10.1016/j.rmcr.2023.101923_bib10 article-title: Human placenta-derived mesenchymal stromal cells: a review from basic research to clinical applications contributor: fullname: de la Torre – volume: 20 issue: 12 year: 2021 ident: 10.1016/j.rmcr.2023.101923_bib2 article-title: Pharmacological treatments for SSc-ILD: systematic review and critical appraisal of the evidence publication-title: Autoimmun. Rev. doi: 10.1016/j.autrev.2021.102978 contributor: fullname: Vonk – volume: 2019 year: 2019 ident: 10.1016/j.rmcr.2023.101923_bib6 article-title: Exosomal miRNA Let-7 from menstrual blood-derived endometrial stem cells alleviates pulmonary fibrosis through regulating mitochondrial DNA damage publication-title: Oxid. Med. Cell. Longev. doi: 10.1155/2019/4506303 contributor: fullname: Sun |
SSID | ssj0000789052 |
Score | 2.2933812 |
Snippet | Interstitial lung disease (ILD) is a severe systemic sclerosis (SSc) complication with no current approved or golden standard treatment. This report aims to... Background: Interstitial lung disease (ILD) is a severe systemic sclerosis (SSc) complication with no current approved or golden standard treatment. This... |
SourceID | doaj pubmedcentral crossref elsevier |
SourceType | Open Website Open Access Repository Aggregation Database Publisher |
StartPage | 101923 |
SubjectTerms | Case Report Extracellular vesicles Interstitial lung disease Mesenchymal stromal cells Systemic sclerosis |
SummonAdditionalLinks | – databaseName: DOAJ Directory of Open Access Journals dbid: DOA link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV1Li9RAEG5kD-JFfOL4og7eJJj0K4m3VVwWYT25sLfQjwobcTKSjIp_0t9kVbpnmVz04iUJSUgXqUq964sQr5xqaiyjKjTWtAlRF01lYqG0UaWrfbAtzztffLLnl_rjlbk6-tUX94QleOD04t6QfUMTNVfraq1D2zrpfUNiE0i3hhz4VOYomFp0MM93GpmnZFJD17QNDAAqFZ9opVpZogWwf2WQ1j2SR0bn7J64m71FOE1U3he3cHwgbl_kevhD8TvlBJYUHwwjkDcHh1lHYGSLHudUa59h1wNjQ0zcHEBCB1_pM4dcn4GexGH3k8wY3HSeA6doYenZ4olJ2PKcUrj-taXjeT_teM9pfyD1Pjk-4o5W-IHz0mnH5DjIsK3pWQk1eggw0w30Tob5LZxC4PVT6eKRuDz78Pn9eZH_0FAEbe2-qBx6jqnq0qGV0ivSn23tq760vY3KEsewibVGizZ6Y2rltSyjdyQPvUOpHouTcTfiEwFVXUWtvUZnKCJEbMoWQ-x9CFY5Utkb8frAre5bAuLoDh1qXzrmbce87RJvN-IdM_TmTgbRXk6QaHVZtLp_idZGmIM4dNkfSX4GPWr46-LNSnZWVKyvjMP1AulNgbmUjW2f_g-6n4k7TE1KFD0XJ_vpO74g12nvXy5fyR_KjB1p priority: 102 providerName: Directory of Open Access Journals – databaseName: ScienceDirect Free and Delayed Access Journal dbid: IXB link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1Nb9QwELWqHhAXxKdYCmgO3FC0ie3YCbe2oqqQygUq7S2yHYcGsdkqWaj6J_lNzNjOilw4cNnNep3Yykxm7Jk3L4y9M6LSPm9FJr3GD9fKrCrKNhOyFLnR1qma6p2vPqvLa_lpU26O2PlcC0OwymT7o00P1jq1rNPdXN_2_foL55SK0Wh6A5EZbYGI25OK-DZnhzgL0ann4cU71D-jE1LtTIR5jVtHtKBcUEPNxcI_BRr_hZtaIif_ckUXj9mjtIaE0zjNJ-zID0_Zg6uUJX_GfsdIQQj8QT8ArvFgroAE4rvo_BQz8BPsOiDGiJEgA6iK8AMffkhZG-hQSXZ36NzggEcHCtxCQHJRHSVsqXrJ3dxv8Xjajzv6pmQAoNEfDR0RzhV--Sng72g6BhKZa7xW5JLuHUzYAe9JP32AU3A0fkxoPGfXFx-_nl9m6b0NmZNK7bPCeEs7LZ0brzi3Aq1qrW3R5apTrVBaSl-1WnrlVWvLUgsred5ag1rSGc_FC3Y87Ab_kkGhi1ZKK70pcZ_ofZXX3rWddU4Jg4Z8xd7P0mpuIz1HM-PWvjck24Zk20TZrtgZCfTQk6i1Q8Nu_NYk3WpwQeXLVlJ6GCfq6tpwayu0Uw6duVPFipWzOjQLTcVL9f8cvFrozmIWy3-G_iYQfeN2nfNK1a_-c8gT9pB-xYjRa3a8H3_6N7iG2tu34SH5A8YKILs priority: 102 providerName: Elsevier – databaseName: Scholars Portal Open Access Journals dbid: M48 link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwlV1ba9VAEF5qBfFFvOLRKvPgm0SS3c0mEaRUsRTh-OSBvoW9xUZ6kpocL_2T_iZnsptqoAi-5M5mk5mdmd2Z-YaxF1qUhU-dSKQvcGOdTMosd4mQuUh1YayqKN95_VGdbOSH0_x0j83ljuIPHK-d2lE9qc1w_urn18tDHPBv_sRqDVtL2J5c0AU0WW6wm1wKSRy_jub-JJkp63MqwsM5FTVA9RrzaK5vZqGrJkj_hcpaRlH-pZaO77I70Z6Eo8AA99ie7-6zW-voMX_AfoVVg2kRENoO0N6DORsSCPui8WPwxo_QN0DoEQOFDyBbwjkKAogeHGiQYfofqOjgKjYdaBEXpqguyqmELWUy2bPLLR6Pu6GnPTkGABXAoOmIYl7hux-nWDzqjoYI7BraCrjSrYURH8B_0o6v4QgsvT84Nx6yzfH7T-9OkljDIbFSqV2SaW9o1lWk2ivOjUAJWxUma1LVKCdUIaUvXSG98sqZPC-EkTx1RiPHNNpz8Yjtd33nHzPIisxJaaTXOc4ZvS_TylvXGGuV0CjUV-zlTK36IkB11HMM25eaaFsTbetA2xV7SwS9epJgtqcL_fC5jqO2RuPK506Sqxg7aqtKc2NKlFkWFbtV2YrlMzvU0WIJlgg21f7z5eWCdxa9WN7p2rMJ9Bun7pyXqnryX1_5lN2ms7BmdMD2d8M3_wytqJ15Pg2N389VIKo priority: 102 providerName: Scholars Portal |
Title | Improvement in the clinical manifestations of interstitial lung disease following treatment with placental mesenchymal stromal cell extracellular vesicles in a patient with systemic sclerosis: A case report |
URI | https://dx.doi.org/10.1016/j.rmcr.2023.101923 https://pubmed.ncbi.nlm.nih.gov/PMC10622869 https://doaj.org/article/317e5d43580744c99a2bb8963c801c61 |
Volume | 46 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV3Nb5VAEN-0NTFejJ_xWX2ZgzdDH7DLAt7aF5tq8qoHm7x4IbvLYmkKNPC08Z_0b3JmF5py8eBlIXwsE2aYmZ35zcDYO8Wz1IYlD4RNcTClCLIoKQMuEh6qVBuZU73z5lyeXYjP22S7x-RUC-NA-0bXR-11c9TWlw5bedOY1YQTW33drHEZE8eZzFf7bD_l_N4a3elfqu1M4rFCxoO5-sZQ88-Y04E85jMr5Jr1z4zRHB95z-CcPmGPR08Rjj1FT9mebZ-xh5sxF_6c_fHxABfeg7oF9ORgqnME6mpR2cHn2QfoKqC-ED0BA1Dg4Bo_cRhzM1ChKHS3aMLgDnUOFJ4Fh9eiakloqEbJXP5ucH_Y9R1tKeQPqNp7RXuEZoVfdnBvj8hRMLZs9XP5jtG1gQEvwHdSDx_gGAw936ctXrCL04_f1mfB-HeGwAgpd0GkrKb1VBoqi-zQHHVnnuqoCmUlSy5TIWxWpsJKK0udJCnXIg5LrVAWKmVj_pIdtF1rXzGI0qgUQgurElwNWpuFuTVlpY2RXKG6XrD3E7eKG9-Eo5jQaVcF8bYg3haetwt2Qgy9u5IaaLsDXf-jGMWoQLfJJqWgJDASavJcxVpnqI0MmmwjowVLJnEoRl_E-xg4Vf3Ph2cz2ZlRMT-D0u3aeU_S_Pr_bz1kj4gGHxp6ww52_U_7Fp2lnV66IAOOn7YnOG5EtmQPztfbL9-X7qv5C-bjIng |
link.rule.ids | 230,315,733,786,790,870,891,2115,3525,24346,27955,27956,45907,53825,53827 |
linkProvider | National Library of Medicine |
linkToHtml | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1Lb9QwELaqIgEXxFMszzlwQ9EmtuMk3NqKaoFuL7TS3iLbcWgQm1TJAuJP9jd1JnZW5MKBSxLZSWxlJjOe12fG3mmRZy6uRCRdhgdbyShP0ioSMhWxzoxVBdU7r8_V6lJ-3qSbA3Yy1cJQWmWQ_V6mj9I6tCzD11xeN83yK-cUislQ9I5AZmgC3ZEp2npUxbc53jtaCE89HnfeoQcieiIUz_g8r35rCReUC2oouJgpqBHHf6an5qmTf-mi04fsQVhEwpGf5yN24NrH7O46hMmfsBvvKhg9f9C0gIs8mEoggQAvajf4EPwAXQ0EGdFTzgDyIvzAvx9C2AZq5JLuN2o32CekA3luYUzlokJK2FL5kr36s8XrYdd3dKZoAKDU7zVdUaIr_HLDmIBH09EQ0Fz9uzyYdGNhwBvwmzTDBzgCS-P7iMZTdnn68eJkFYWNGyIrldpFiXaGTK0s1k5xbgSK1SIzSR2rWlVCZVK6vMqkU05VJk0zYSSPK6ORTWrtuHjGDtuudc8ZJFlSSWmk0ykais7lceFsVRtrldAoyRfs_USt8trjc5RT4tr3kmhbEm1LT9sFOyaC7u8kbO2xoeu_lYG5SlxRubSSFB_Gidqi0NyYHAWVRW1uVbJg6cQO5YxV8VXNPwfPZ7wzm8W8p22uRqRvtNc5z1Xx4j-HfMvurS7WZ-XZp_MvL9l96vHuo1fscNf_dK9xQbUzb8Yf5hZReCPg |
linkToPdf | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1Lb9NAEF5BkSouvBHhOQduyIntXa9tbqUQlUeqHqhUiYO1L1ND40S2C4IfyW9ixmtXNQcOvcSWvVmPnc87szvffGHspeJZ6kLLA-FS_DBWBFmU2ICLhIcq1UbmVO-8OpQHx-LDSXIysCrbgVZZG13N67P1vK5Oe27ldm0WI09scbTax2lMHGcyX2xtubjObuBLG6eXZur9KEwVnkk81Ml4SlezNiQBGnM6kMd84ot6yf6JS5qyJC-5neVt9mU02LNNvs_POz03v__RcrzaHd1ht4ZoFPZ8m7vsmqvvsd3VkG-_z_74NYd-CRGqGjBahLGWEkg5o3Stz-W3sCmBtCcaIh8gqOEMhxEY8j9QItw2P9FNwgWzHWgJGHpOGFVkwprqoMzprzXut12zoS2lFQDdR6Nojxiz8MO1_f2QOQoGWVjfl1elrgy02ACfeNW-hj0wdH2fGnnAjpfvPu8fBMM_QARGSNkFkXKa5mxpqBw-IM1xfM5THZWhLKXlMhXCZTYVTjppdZKkXIs4tFoh3krlYv6Q7dSb2j1iEKWRFUILpxKccTqXhbkzttTGSK7QJczYqxELxdYLfRQjA-5bQcgpCDmFR86MvSG4XLQkke7-wKb5Wgw_bIGhmUusoEQzGmryXMVaZzjiGQwLjIxmLBnBVgzxjo9jsKvqvxfPJsicWDE9g3jrJcNHfD2--ldfsN2jt8vi0_vDj0_YTTLHr0Q9ZTtdc-6eYWzW6ef9S_gXQBJCmQ |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Improvement+in+the+clinical+manifestations+of+interstitial+lung+disease+following+treatment+with+placental+mesenchymal+stromal+cell+extracellular+vesicles+in+a+patient+with+systemic+sclerosis%3A+A+case+report&rft.jtitle=Respiratory+medicine+case+reports&rft.au=Assar%2C+Shirin&rft.au=Mohammadzadeh%2C+Dena&rft.au=Norooznezhad%2C+Amir+Hossein&rft.au=Payandeh%2C+Mehrdad&rft.date=2023-01-01&rft.issn=2213-0071&rft.eissn=2213-0071&rft.volume=46&rft.spage=101923&rft_id=info:doi/10.1016%2Fj.rmcr.2023.101923&rft.externalDBID=n%2Fa&rft.externalDocID=10_1016_j_rmcr_2023_101923 |
thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=2213-0071&client=summon |
thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=2213-0071&client=summon |
thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=2213-0071&client=summon |